Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q05CL8

Entry ID Method Resolution Chain Position Source
AF-Q05CL8-F1 Predicted AlphaFoldDB

51 variants for Q05CL8

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388657813 43 A>V No EVA
rs230606323 49 K>R No EVA
rs3388662048 57 K>T No EVA
rs3388659875 62 Y>* No EVA
rs3388662020 86 R>I No EVA
rs3388655703 90 S>G No EVA
rs3388644872 136 E>V No EVA
rs3388657753 137 R>S No EVA
rs3388657807 139 F>C No EVA
rs3388666173 159 P>H No EVA
rs3388659902 160 K>* No EVA
rs3388652167 160 K>R No EVA
rs3388657800 161 G>R No EVA
rs3413058504 188 P>L No EVA
rs259105611 207 R>Q No EVA
rs581241976 209 A>T No EVA
rs3388644891 219 K>E No EVA
rs3388651100 224 K>N No EVA
rs13462046 242 V>L No EVA
rs583847846 257 E>G No EVA
rs3388663044 271 K>* No EVA
rs3388660999 272 K>R No EVA
rs3388652059 273 K>M No EVA
rs50312911 287 A>S No EVA
rs3388651170 298 E>V No EVA
rs244766811 317 G>S No EVA
rs3388659791 339 K>N No EVA
rs3388658443 340 E>G No EVA
rs1134900248 347 S>P No EVA
rs3388658494 360 K>Q No EVA
rs3388662002 361 E>V No EVA
rs3388659883 362 R>S No EVA
rs3388666991 363 H>D No EVA
rs3388651133 363 H>G* No EVA
rs3388659886 363 H>L No EVA
rs252370177 372 L>M No EVA
rs3388652178 372 L>S No EVA
rs1133640676 382 D>A No EVA
rs1133308786 384 K>R No EVA
rs3388655706 426 C>Y No EVA
rs3388658488 441 T>N No EVA
rs212766778 498 Q>H No EVA
rs231156249 506 S>C No EVA
rs3388657779 540 R>G No EVA
rs3412945302 551 K>Q No EVA
rs3393655714 555 A>C* No EVA
rs3388652173 556 K>* No EVA
rs3393655714 556 K>C No EVA
rs3388652173 556 K>E No EVA
rs3388644863 556 K>M No EVA
rs3388664772 568 E>Q No EVA

No associated diseases with Q05CL8

6 regional properties for Q05CL8

Type Name Position InterPro Accession
domain RNA recognition motif domain 119 - 196 IPR000504
domain La-type HTH domain 22 - 116 IPR006630
domain La protein, xRRM domain 438 - 551 IPR014886
domain LARP7, RNA recognition motif 1 120 - 199 IPR034887
domain LARP7, RNA recognition motif 2 442 - 523 IPR034910
domain La-related protein 7, La domain 25 - 105 IPR034946

Functions

Description
EC Number
Subcellular Localization
  • Nucleus, nucleoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
7SK snRNP A ribonucleoprotein complex that contains the 7SK snRNA. The 7SK snRNP plays a central role in RNA polymerase II elongation control by regulating the availability of active P-TEFb.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
ribonucleoprotein complex A macromolecular complex that contains both RNA and protein molecules.
small nuclear ribonucleoprotein complex A ribonucleoprotein complex that contains at least one RNA of the small nuclear RNA (snRNA) class and as well as its associated proteins. These are typically named after the snRNA(s) they contain, e.g. U1 snRNP, U4/U6 snRNP, or 7SK snRNP. Many, of these complexes become part of the spliceosome involved in splicing of nuclear mRNAs. Others are involved in regulation of transcription elongation or 3'-end processing of replication-dependent histone pre-mRNAs.

3 GO annotations of molecular function

Name Definition
7SK snRNA binding Binding to a 7SK small nuclear RNA (7SK snRNA).
RNA binding Binding to an RNA molecule or a portion thereof.
U6 snRNA binding Binding to a U6 small nuclear RNA (U6 snRNA).

14 GO annotations of biological process

Name Definition
box C/D RNA 3'-end processing Any process involved in forming the mature 3' end of a box C/D RNA molecule.
cell differentiation The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
germ cell proliferation The multiplication or reproduction of germ cells, reproductive cells in multicellular organisms, resulting in the expansion of a cell population.
mRNA processing Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.
negative regulation of chromatin binding Any process that stops or reduces the frequency, rate or extent of chromatin binding. Chromatin binding is the selective interaction with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
negative regulation of viral transcription Any process that stops, prevents, or reduces the frequency, rate or extent of viral transcription.
positive regulation of G1/S transition of mitotic cell cycle Any signalling pathway that increases or activates a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle.
positive regulation of protein localization to Cajal body Any process that activates or increases the frequency, rate or extent of protein localization to Cajal body.
positive regulation of snRNA transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of snRNA transcription mediated by RNA polymerase II.
regulation of mRNA splicing, via spliceosome Any process that modulates the frequency, rate or extent of mRNA splicing via a spliceosomal mechanism.
RNA splicing The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.
spermatogenesis The developmental process by which male germ line stem cells self renew or give rise to successive cell types resulting in the development of a spermatozoa.
U6 2'-O-snRNA methylation The posttranscriptional addition a methyl group to the 2'-oxygen atom of a nucleotide residue in an U6 snRNA molecule.

11 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8N9W6 BOLL Protein boule-like Homo sapiens (Human) PR
P42696 RBM34 RNA-binding protein 34 Homo sapiens (Human) PR
Q4G0J3 LARP7 La-related protein 7 Homo sapiens (Human) PR
P05455 SSB Lupus La protein Homo sapiens (Human) PR
Q924M5 Boll Protein boule-like Mus musculus (Mouse) PR
Q8C854 Myef2 Myelin expression factor 2 Mus musculus (Mouse) PR
Q6ZQ58 Larp1 La-related protein 1 Mus musculus (Mouse) PR
Q5XI01 Larp7 La-related protein 7 Rattus norvegicus (Rat) PR
Q9S7N9 CID12 Polyadenylate-binding protein-interacting protein 12 Arabidopsis thaliana (Mouse-ear cress) PR
Q93ZV7 LA1 La protein 1 Arabidopsis thaliana (Mouse-ear cress) PR
Q4KM14 trnau1apl tRNA selenocysteine 1-associated protein 1-like Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
METENQKTME ESTKRKEEKK KRSRVKQVLA DIAKQVDFWF GDANLHKDKF LREQIEKSRD
70 80 90 100 110 120
GYVDISLLVS FNKMKKLTTD GKLIARALKS SSVVELDLEG TRIRRKKPLG ERPKDEEERT
130 140 150 160 170 180
VYVELLPKNV THSWIERVFG KCGNVVYISI PHYKSTGDPK GFAFVEFETK EQAAKAIEFL
190 200 210 220 230 240
NNPPEEAPRK PGIFPKTVKN KPIPSLRVAE EKKKKKKKKG RIKKEESVQA KESAVDSSSS
250 260 270 280 290 300
GVCKATKRPR TASEGSEAET PEAPKQPAKK KKKRDKVEAS SLPEARAGKR ERCSAEDEDC
310 320 330 340 350 360
LPPRPKAKKR AQKDGVGQAA SEVSKESRDL EFCSTEEEKE TDRKGDSLSK VKRKHKKKHK
370 380 390 400 410 420
ERHKMGEEVI PLRVLSKTEW MDLKKEYLAL QKASMASLKK TISQIKLESE METDCKAPTA
430 440 450 460 470 480
GSGQECSTQE KVSAQGPQFV TGVIVKIVSG EPLPGRKQVK DILATISEVV YIDLLEGDTE
490 500 510 520 530 540
CHARFKTPED AQAVMNAQTE IRKKHSWNLE VLSGDHEQRY WQKILVDRQA KLNQPREKKR
550 560
GTEKLITKAE KIRLAKTQQA SQHIRFSEYD